Nukkleus (DFNS) Stock Price, News & Analysis

Company Overview

Nukkleus, Inc. (NASDAQ: DFNS) is a technology company focused on defense and security-related solutions. Its activities include developing and supporting technologies intended for government and commercial customers, with an emphasis on emerging defense applications and related infrastructure.

The company previously operated primarily in financial technology. Through its digital-finance businesses, Nukkleus provided technology and infrastructure for electronic trading, foreign-exchange transactions, liquidity management, risk controls and brokerage operations. Its more recent strategy has expanded beyond those activities as it pursues opportunities in the defense technology and government-contracting markets.

Nukkleus is headquartered in the United States and has operated through a combination of internal businesses, subsidiaries and strategic acquisitions. The company’s operations and leadership structure may continue to evolve as it executes its broader defense-focused strategy.

Key Stats

• Today's Range: $5.71 to $5.96
• 50-Day Range: $5.75 to $47.36
• 52-Week Range: $3.70 to $1,948.75
• Volume: 121,192 shs
• Average Volume: 297,853 shs
• Market Capitalization: $9.55 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Moderate Buy

Nukkleus Stock Analysis - MarketRank™

Nukkleus scored higher than 26% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Nukkleus has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Nukkleus has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Nukkleus are expected to grow in the coming year, from ($3.90) to ($3.21) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Nukkleus is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Nukkleus is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

18.68% of the float of Nukkleus has been sold short.

Short Interest Ratio / Days to Cover

Nukkleus has a short interest ratio ("days to cover") of 0.95, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Nukkleus has recently decreased by 18.99%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Nukkleus does not currently pay a dividend.

Dividend Growth

Nukkleus does not have a long track record of dividend growth.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 1.79

News Sentiment

Nukkleus has a news sentiment score of 1.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Industrials companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Nukkleus this week, compared to 3 articles on an average week.

Search Interest

Only 1 people have searched for DFNS on MarketBeat in the last 30 days. This is a decrease of -90% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Nukkleus to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 0.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Nukkleus insiders have not sold or bought any company stock.

Percentage Held by Insiders

11.14% of the stock of Nukkleus is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

12.47% of the stock of Nukkleus is held by institutions.

Company Calendar

• Last Earnings: 8/19/2026
• Today: 10/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Industrials
• Industry: Aerospace & Defense
• Sub-Industry: Aerospace & Defense
• Current Symbol: NASDAQ:DFNS
• Previous Symbol: NASDAQ:NUKK
• CIK: 1787518
• Web: www.nukk.com
• Phone: 212-791-4663
• Fax: N/A
• Employees: 12
• Year Founded: 2013

Profitability

• EPS (Trailing Twelve Months): ($397.10)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $78.55 million
• Net Margins: N/A
• Pretax Margin: -1,854.62%
• Return on Equity: N/A
• Return on Assets: -26.92%

Debt

• Debt-to-Equity Ratio: 0.07
• Current Ratio: 0.14
• Quick Ratio: 0.11

Sales & Book Value

• Annual Sales: $5.91 million
• Price / Sales: 1.62
• Cash Flow: $575.00 per share
• Price / Cash Flow: 0.01
• Book Value: ($90.93) per share
• Price / Book: -0.06

Miscellaneous

• Outstanding Shares: 1,660,000
• Free Float: 1,479,000
• Market Cap: $9.55 million
• Optionable: N/A
• Beta: -6.05